Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model11Published on the World Wide Web on 10 October 2000.
- 1 December 2000
- journal article
- review article
- Published by Elsevier in Brain Research
- Vol. 886 (1-2), 82-98
- https://doi.org/10.1016/s0006-8993(00)02915-2
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Lentiviral Vectors: Regulated Gene ExpressionMolecular Therapy, 2000
- Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's DiseaseHuman Gene Therapy, 2000
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of ExpressionHuman Gene Therapy, 1999
- Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in BrainHuman Gene Therapy, 1998
- Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus VectorsExperimental Neurology, 1998
- PET studies of functional compensation in a primate model of Parkinsonʼs diseaseNeuroReport, 1997
- Immune responses to adenovirus vectors in the nervous systemTrends in Neurosciences, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991